| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Radiobiology [M. J. A-T., G. M. B.] and Molecular Oncology Programs [R. S. D.], Cross Cancer Institute, Edmonton, Alberta T6G 1Z2, and Department of Biological Sciences, University of Calgary, Calgary, Alberta T2N 1N4 [L. G. L., S. P. L-M.], Canada
Lack of DNA-dependent protein kinase (DNA-PK) activity confers radiosensitivity and defective DNA double-strand break repair. Nine human malignant glioma cell lines were studied to determine whether differences in DNA-PK activity reflect differences in inherent radiosensitivity or are predictive of tumor treatment response. DNA-PK activity was present in all cell extracts, as were the DNA-PK proteins, DNA-PK catalytic subunit, Ku p70, and Ku p80. No correlation was found between the levels of DNA-PK activity and inherent radiosensitivity or in the tumor treatment response. These preliminary results suggest that variation in DNA-PK activity may not be a determinant of clinical response in malignant glioma.
1 This work was supported by awards from the National Cancer Institute of Canada with funds provided by the Canadian Cancer Society, the Natural Sciences and Engineering Research Council (NSERC) (Canada), and the Alberta Cancer Board. S. P. L-M. is the recipient of an NSERC Women's Faculty Award.
2 To whom requests for reprints should be addressed, at Radiobiology, Cross Cancer Institute, 11560 University Avenue, Edmonton, Alberta T6G 1Z2, Canada.
Received 8/23/95. Accepted 10/ 4/95.
This article has been cited by other articles:
![]() |
F. Karimi-Busheri, A. Rasouli-Nia, J. Allalunis-Turner, and M. Weinfeld Human Polynucleotide Kinase Participates in Repair of DNA Double-Strand Breaks by Nonhomologous End Joining but not Homologous Recombination Cancer Res., July 15, 2007; 67(14): 6619 - 6625. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Stiff, M. O'Driscoll, N. Rief, K. Iwabuchi, M. Lobrich, and P. A. Jeggo ATM and DNA-PK Function Redundantly to Phosphorylate H2AX after Exposure to Ionizing Radiation Cancer Res., April 1, 2004; 64(7): 2390 - 2396. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. I. Belenkov, J.-P. Paiement, L. C. Panasci, B. P. Monia, and T. Y. K. Chow An Antisense Oligonucleotide Targeted to Human Ku86 Messenger RNA Sensitizes M059K Malignant Glioma Cells to Ionizing Radiation, Bleomycin, and Etoposide but not DNA Cross-Linking Agents Cancer Res., October 15, 2002; 62(20): 5888 - 5896. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Gately, J. C. Hittle, G. K. T. Chan, and T. J. Yen Characterization of ATM Expression, Localization, and Associated DNA-dependent Protein Kinase Activity Mol. Biol. Cell, September 1, 1998; 9(9): 2361 - 2374. [Abstract] [Full Text] |
||||
![]() |
P. Douglas, G. B. G. Moorhead, R. Ye, and S. P. Lees-Miller Protein Phosphatases Regulate DNA-dependent Protein Kinase Activity J. Biol. Chem., May 25, 2001; 276(22): 18992 - 18998. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Yannone, S. Roy, D. W. Chan, M. B. Murphy, S. Huang, J. Campisi, and D. J. Chen Werner Syndrome Protein Is Regulated and Phosphorylated by DNA-dependent Protein Kinase J. Biol. Chem., October 5, 2001; 276(41): 38242 - 38248. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |